Public M&A: Experience

  • Permanent TSB Group Holdings plc on its formal sales process and €1.62 billion recommended offer by BAWAG
  • Irish Continental Group plc on its recommended €1.2 billion MBO through Bluefin Bidco
  • Barclays Bank, as lead lenders and arrangers, on KKR and EnergyCap’s £5.75 billion recommended offer for DCC plc
  • JPMorgan Chase Bank, as Alkermes lender, on Alkermes $2.1 billion acquisition of Avadel plc
  • Dalata Hotel Group plc on its formal sales process $1.4 billion acquisition by Pandox AB and Eiendomsspar AS
  • K1 Investment Management LLC on its P2P acquisition of MariaDB by way of tender offer
  • Endo, Inc. on its $6.7 billion merger with Mallinckrodt plc
  • Hibernia REIT plc on its €1.09bn recommended takeover offer from the Brookfield Group 
  • ICON plc on its $12bn acquisition of PRA Life Sciences, Inc. in a cash and share deal
  • UDG Healthcare plc on its £2.6bn recommended takeover offer from Clayton Dubilier & Rice
  • Xeris Pharmaceuticals, Inc. on its acquisition of Strongbridge Biopharma plc
  • B&J Holdings and the bidco on the proposed €718m recommended takeover of AppleGreen plc
  • Henderson Park on its €1.34bn recommended takeover offer for Green REIT plc
  • The Stars Group on its merger with Flutter Entertainment Plc (Paddy Power Betfair)
  • Abbey plc and its independent directors on an unconditional offer by its majority shareholder
  • Morgan Stanley, as AbbVie's lead financial advisor and lender, on AbbVie's $63bn acquisition of Allergan plc
  • Sumitomo Corporation on its €751m recommended takeover offer for Fyffes plc
  • Verizon Communications on its acquisition of FleetMatics Group for $2.4bn
  • Johnson Controls Inc on its $20bn merger with Tyco plc
  • Medtronic Inc on its $49bn acquisition of Covidien plc
  • Towers Watson plc on its merger with Willis Group
  • International Power Plc on the court approved cross-border amalgamation of its Irish, Italian and Hungarian businesses
  • Perrigo Company plc on its successful defence of a hostile takeover attempt by Mylan N.V.
  • Endo International plc on its acquisition of Par Pharmaceutical Holdings, Inc for $8.05bn
  • XL Group on its $4.2bn acquisition of Catlin Group
  • Takeda on Irish aspects of its €65.7bn acquisition of Irish headquartered Shire plc